Divi's Laboratories (NSE:DIVISLAB) Price-to-Tangible-Book: (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
87 GF Score
Price ₹9,198.00
GF Value ₹7,268.12
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Divi's Laboratories Price-to-Tangible-Book?

As of today (2026-09-16), Divi's Laboratories's share price is ₹9198.00. Divi's Laboratories's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was ₹0.00. Hence, Divi's Laboratories's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Divi's Laboratories's Price-to-Tangible-Book or its related term are showing as below:

NSE:DIVISLAB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.09   Med: 8.11   Max: 14.77
Current: 14.57

During the past 13 years, Divi's Laboratories's highest Price to Tangible Book Ratio was 14.77. The lowest was 3.09. And the median was 8.11.

NSE:DIVISLAB's Price-to-Tangible-Book is ranked worse than
93.56% of 839 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs NSE:DIVISLAB: 14.57

A closely related ratio is called PB Ratio. As of today, Divi's Laboratories's share price is ₹9198.00. Divi's Laboratories's Book Value per Sharefor the quarter that ended in Jun. 2026 was ₹0.00. Hence, Divi's Laboratories's P/B Ratio of today is .


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Divi's Laboratories Price-to-Tangible-Book Related Terms


Divi's Laboratories Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Price-to-Tangible-Book Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.97 5.87 6.74 10.25 9.42

Divi's Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9.80 0.00 9.42 0.00

NSE:DIVISLAB vs ZTS: Price-to-Tangible-Book Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories Price-to-Tangible-Book vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Price-to-Tangible-Book falls into.


NSE:DIVISLAB
87GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Price-to-Tangible-Book Calculation

Divi's Laboratories's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=9198.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹9,198.00 is trading 26.6% above its estimated GF Value™ of ₹7,268.12. GuruFocus considers Divi's Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:DIVISLAB:

  • Price-to-Tangible-Book:
  • GF Value™: ₹7,268.12 vs. price of ₹9,198.00 (26.6% above fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
87GF Score

Get the complete analysis for NSE:DIVISLAB

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9,198.00
Price
₹7,268.12
GF Value